Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Current Deferred Revenue (2018 - 2025)

Argan's Current Deferred Revenue history spans 8 years, with the latest figure at $451.9 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue rose 66.95% year-over-year to $451.9 million; the TTM value through Oct 2025 reached $451.9 million, up 66.95%, while the annual FY2025 figure was $299.2 million, 65.28% up from the prior year.
  • Current Deferred Revenue for Q4 2025 was $451.9 million at Argan, up from $316.8 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $451.9 million in Q4 2025 and bottomed at $49.0 million in Q4 2022.
  • The 5-year median for Current Deferred Revenue is $178.7 million (2021), against an average of $192.4 million.
  • The largest annual shift saw Current Deferred Revenue plummeted 72.21% in 2022 before it skyrocketed 218.51% in 2023.
  • A 5-year view of Current Deferred Revenue shows it stood at $176.4 million in 2021, then tumbled by 72.21% to $49.0 million in 2022, then surged by 218.51% to $156.2 million in 2023, then surged by 73.33% to $270.7 million in 2024, then skyrocketed by 66.95% to $451.9 million in 2025.
  • Per Business Quant, the three most recent readings for AGX's Current Deferred Revenue are $451.9 million (Q4 2025), $316.8 million (Q3 2025), and $283.8 million (Q2 2025).